December 19, 2022

Plasma Pharmacokinetics and Pharmacodynamic Effects of the 2-benzylbenzimidazole Synthetic Opioid

The aims of the present study were to investigate the pharmacokinetics of isotonitazene in rats, and relate pharmacokinetic parameters to pharmacodynamic effects.

December 14, 2022

Early-Career Forensic Toxicologists Take Home Top Awards for NIJ-Funded Research

Bench scientists and student researchers are often under-represented at forensic science conferences due to budgetary constraints. To encourage the participation of young researchers, the Society of Forensic Toxicologists (SOFT) supports three prestigious awards: the Young Scientist Meeting Award, the Master Level Educational Research Award, and the Doctorate Level Educational Research Award. This year, NIJ-funded researchers earned recognition for their exceptional work in each of the three categories....

December 13, 2022

Exclusive: $12M Center for Diagnostics Discovery Under Development in Horsham

Space that previously housed an insurance company's mail order pharmacy is being transformed into a home for fledgling entrepreneurs working on "cutting-edge" diagnostic products and processes to improve how and when diseases are detected.

The $12 million incubator project,called the Center for Diagnostics Discovery, is the brainchild of Eric Rieders , an owner and former CEO of NMS Labs, a Horsham-based bioanalytical toxicology and forensicsciences laboratory.

The Center for Diagnostics Discovery is being created in about 50,000 square feet of space last leased by Cigna in the 150,000-square-foot building that houses NMS Labs. The building at 206 Welsh Road is owned by the Rieders family, which founded NMS Labs.

November 10, 2022

CFSRE Forensic Toxicologist Sara Walton Receives 2022 SOFT Young Scientist Meeting Award

The Society of Forensic Toxicology (SOFT) Awards Committee selected CFSRE’s Forensic Toxicologist, Sara Walton, as this year’s Young Scientist Meeting Award (YSMA) recipient! This award recognizes young scientists performing outstanding forensic toxicology research. Help us in congratulating Sara for this prestigious award!

The title of her abstract was “Pharmacology and Toxicology of N-Pyrrolidino Etonitazene – A New Nitazene Synthetic Opioid Increasingly Observed in Forensic Cases”. This research was funded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (Award Number 2020-DQ-BX-0007, “Real-Time Sample-Mining and Data-Mining Approaches for the Discovery of Novel Psychoactive Substances (NPS)”). The opinions, findings, conclusions and/or recommendations expressed in this presentation are those of the author(s) and do not necessarily reflect those of the Department of Justice.

May 3, 2022

Emergent Synthetic Stimulant Replacing Drug Sold as Ecstasy, Molly

In 2020 and 2021, the Schedule I drug eutylone—typically sold as ecstasy, Molly or MDMA—was the most commonly encountered synthetic stimulant in forensic casework. While regulated in countries beside the U.S., including Canada, the UK, Sweden and Germany, eutylone is not controlled under the 1961, 1971 or 1988 United Nations Conventions. Stakeholders are seeking to change that.

April 29, 2022

New Publication - N-Pyrrolidino Etonitazene

Congrats to our staff and collaborators for the publication of
“Pharmacological evaluation and forensic case series of N‐pyrrolidino etonitazene (etonitazepyne), a newly emerging 2‐benzylbenzimidazole ‘nitazene’ synthetic opioid”.

March 17, 2022

Identifying Novel Psychoactive Substances: NIJ-Funded Research in Action

The DEA has issued a notice of intent to publish a temporary order to schedule seven synthetic benzimidazole-opioid substances in schedule I of the Controlled Substances Act.

Read More

March 15, 2022

AAFS – Dr. Alex Krotulski Received The Irving Sunshine Award

February 21, 2022 – AAFS

Our Assistant Director, Dr. Alex Krotulski received the Irving Sunshine Award — Outstanding Research by a Young Investigator at this year's AAFS conference.
This award is given for outstanding research by a young investigator in forensic toxicology. This award aims to acknowledge contributions made to the profession in the early stages of the recipient's career, or within the first seven years of completing their highest educational degree.

Read More

February 10, 2022

TIAFT | Award Winners Announced at TIAFT Virtual

Our Executive Director, Dr. Barry Logan, received the highest TIAFT distinction, the Alan Curry Award, for a long history of distinguished contributions to the field of forensic toxicology.

Read More

January 27, 2022

Brazilian Journal of Analytical Chemistry’s Interview with Barry Logan

Our Executive Director and the Founder of the CFSRE, Dr Barry Logan was recently honored by the Brazilian Journal of Analytical Chemistry on his career and achievements in forensic and analytical toxicology. In the interview he reflects on what it means to be a researcher and scientist today, changes in the academic journey, responsibilities of senior professionals to support and grow tomorrows leaders, and the importance of international collaboration.
Read More